Société Corvus Pharmaceuticals, Inc.
Actions
CRVS
US2210151005
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,92 USD | +10,98% | +32,41% | +9,09% |
Métier
Nombre d'employés: 28
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27/01/14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27/01/14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21/07/22 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/19 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | - | 06/02 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27/01/14 |
Ian Clark
BRD | Director/Board Member | 62 | 03/01/17 |
Terry Gould
BRD | Director/Board Member | 67 | 01/11/14 |
Peter Thompson
FOU | Founder | 64 | 27/01/14 |
Linda Grais
BRD | Director/Board Member | 68 | 28/01/19 |
Scott Morrison
BRD | Director/Board Member | 66 | 01/12/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 49 038 582 | 43 846 630 ( 89,41 %) | 0 | 89,41 % |
Coordonnées société
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+9,09% | 94,15 M | |
+25,69% | 47,86 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,66 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+28,07% | 12,14 Md | |
+0,17% | 12,15 Md | |
-1,24% | 11,99 Md |
- Bourse
- Actions
- Action CRVS
- Société Corvus Pharmaceuticals, Inc.